Computational Biology

Computational Biology

Global Computational Biology Market to Reach $25.4 Billion by 2030
The global market for Computational Biology estimated at US$8 Billion in the year 2023, is expected to reach US$25.4 Billion by 2030, growing at a CAGR of 15.6% over the period 2023-2030. Contract Services, one of the segments analyzed in the report, is expected to record 16.5% CAGR and reach US$18 Billion by the end of the analysis period. Growth in the In-House Services segment is estimated at 13.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 14.7% CAGR
The Computational Biology market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.8% and 13.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

What to Expect the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 11 Featured) -
  • Certara LP
  • Chemical Computing Group ULC
  • Compugen Ltd.
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Therapeutics
  • Rosa & Co. LLC
  • Schrodinger LLC
  • Simulations Plus, Inc.
  • Strand Life Sciences Pvt., Ltd.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Computational Biology - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World 7-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Contract Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 4: World 7-Year Perspective for Contract Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World 7-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World 7-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 9: World Computational Biology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 10: World Recent Past, Current & Future Analysis for Computational Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World 7-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Drug Discovery & Disease Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 13: World 7-Year Perspective for Drug Discovery & Disease Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cellular & Biological Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World 7-Year Perspective for Cellular & Biological Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World 7-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Preclinical Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 19: World 7-Year Perspective for Preclinical Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Human Body Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World 7-Year Perspective for Human Body Simulation Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World 7-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 24: USA Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 25: USA 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: USA 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 28: USA Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 29: USA 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
CANADA
TABLE 30: Canada Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 31: Canada 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 34: Canada Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 35: Canada 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
JAPAN
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 36: Japan Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 37: Japan 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 40: Japan Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 41: Japan 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
CHINA
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 42: China Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 43: China 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: China 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 46: China Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 47: China 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
EUROPE
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 48: Europe Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 49: Europe 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 52: Europe Recent Past, Current & Future Analysis for Computational Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 53: Europe 7-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
TABLE 54: Europe Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 55: Europe 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
FRANCE
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: France 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 58: France Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 59: France 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 60: France Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 61: France 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
GERMANY
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 64: Germany Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 65: Germany 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 66: Germany Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 67: Germany 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 70: Italy Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 71: Italy 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 72: Italy Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 73: Italy 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
UNITED KINGDOM
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: UK 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 76: UK Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 77: UK 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 78: UK Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 79: UK 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
REST OF EUROPE
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Rest of Europe 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 83: Rest of Europe 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 85: Rest of Europe 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
ASIA-PACIFIC
Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Asia-Pacific 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 89: Asia-Pacific 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 91: Asia-Pacific 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
REST OF WORLD
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of World 7-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2024 & 2030
TABLE 94: Rest of World Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 95: Rest of World 7-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2024 & 2030
TABLE 96: Rest of World Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 97: Rest of World 7-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings